BIIB
USDBiogen Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$155.700
Máximo
$156.220
Mínimo
$154.010
Volumen
1.72M
Fundamentos de la Empresa
Capitalización de Mercado
22.7B
Industria
Drug Manufacturers - General
País
United States
Estadísticas de Negociación
Volumen Promedio
1.64M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157
Bernstein analyst William Pickering maintains Biogen with a Market Perform and raises the price target from $155 to $157.
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210
RBC Capital analyst Brian Abrahams maintains Biogen with a Outperform and lowers the price target from $217 to $210.
Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline
Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple sclerosis treatments.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.